We are live on ! Find out more
CSBR icon

Champions Oncology

47 hedge funds and large institutions have $76.9M invested in Champions Oncology in 2020 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 12 increasing their positions, 19 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

33% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 3

24% more capital inflows, than outflows

Capital inflows: $4.82M | Capital outflows: $3.89M

2% more funds holding

Funds holding: 46 → 47 (+1)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

2.32% less ownership

Funds ownership: 55.66% → 53.34% (-2.3%)

37% less repeat investments, than reductions

Existing positions increased: 12 | Existing positions reduced: 19

Holders
47
Holders Change
+1
Holders Change %
+2.17%
% of All Funds
0.83%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
4
Increased
12
Reduced
19
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

CSBR Hedge Fund Activity: Q4 2020 in Review

47 of the 5,678 institutional investors tracked by Wall St. Rank reported a position in Champions Oncology (CSBR) for Q4 2020, worth a combined $76.9M — up 17% from $65.5M a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new CSBR positions and 3 closed out — a net gain of 1 holder — while 12 added to existing stakes and 19 trimmed.

The largest buyer was Roubaix Capital, opening a new position worth an estimated $2.13M. The largest seller was Vanguard Group, cutting an estimated $2.21M.

  • 47 institutional investors held Champions Oncology (CSBR) as of Q4 2020, up from 46 in Q3 2020.
  • Funds reported $76.9M of Champions Oncology stock for Q4 2020, up 17% quarter-over-quarter.
  • 4 funds opened new Champions Oncology positions in Q4 2020 and 3 closed out, a net change of +1 holder.
  • The largest Champions Oncology buyer in Q4 2020 was Roubaix Capital, an estimated $2.13M added.
  • The largest Champions Oncology seller in Q4 2020 was Vanguard Group, an estimated $2.21M sold.

Based on aggregated 13F filings for Q4 2020.